Biopharmaceutical company CureVac N.V. (CVAC) reported Wednesday a pre-tax loss of 112.2 million euros for the first quarter of 2021, sharply wider than a pre-tax loss of 23.9 million euros in the prior-year quarter.
from RTT - Earnings https://ift.tt/3vqslmu
via IFTTT
No comments:
Post a Comment